| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
185,611,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
6,246,627 |
Avg
Vol: |
2,871,156 |
| 52
Week Range: |
$23.99 - $23.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Berstein David L |
Senior VP, Chief IP Officer |
• • – |
2013-07-18 |
4 |
AS |
$19.79 |
$158,290 |
D/D |
(8,000) |
216,898 |
|
- |
|
| Keane Raymond T |
SVP General Counsel & CCO |
• • – |
2013-07-18 |
4 |
AS |
$19.79 |
$158,286 |
D/D |
(8,000) |
62,096 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs |
• • – |
2013-07-18 |
4 |
AS |
$19.79 |
$158,299 |
D/D |
(8,000) |
67,724 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• • – |
2013-07-18 |
4 |
AS |
$19.79 |
$277,045 |
D/D |
(14,000) |
378,900 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-07-17 |
4 |
AS |
$19.60 |
$52,912 |
I/I |
(2,700) |
5,857 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-07-17 |
4 |
AS |
$19.61 |
$980,705 |
D/D |
(50,000) |
1,355,861 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-07-16 |
4 |
AS |
$20.97 |
$56,623 |
I/I |
(2,700) |
8,557 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-07-16 |
4 |
AS |
$19.91 |
$2,866,478 |
D/D |
(144,000) |
1,405,861 |
|
- |
|
| Haluska Frank |
SVP, Clinical R&D, CMO |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
89,907 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
136,378 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,000 |
392,900 |
|
- |
|
| Keane Raymond T |
SVP General Counsel & CCO |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
70,096 |
|
- |
|
| Dodion Pierre F |
SVP, Corp. Dev. & Operations |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
73,682 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
75,724 |
|
- |
|
| Berstein David L |
Senior VP, Chief IP Officer |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
224,898 |
|
- |
|
| Duvall Martin J |
SVP, Commercial Operations |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,600 |
9,739 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-07-15 |
4 |
D |
$20.98 |
$729,600 |
D/D |
(34,776) |
1,549,861 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
73,600 |
1,584,637 |
|
- |
|
| Fitzgerald Edward M |
Executive VP, CFO |
• • – |
2013-07-15 |
4 |
D |
$20.98 |
$277,565 |
D/D |
(13,230) |
214,585 |
|
- |
|
| Fitzgerald Edward M |
Executive VP, CFO |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,000 |
227,815 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-06-19 |
4 |
AS |
$18.00 |
$104,415 |
D/D |
(5,800) |
1,511,037 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-06-19 |
4 |
AS |
$18.00 |
$97,208 |
I/I |
(5,400) |
11,257 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-05-15 |
4 |
AS |
$18.14 |
$48,983 |
I/I |
(2,700) |
16,657 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-05-15 |
4 |
AS |
$18.22 |
$675,970 |
D/D |
(37,098) |
1,516,837 |
|
- |
|
| Berger Harvey J MD |
Chairman & CEO |
• • – |
2013-05-14 |
4 |
AS |
$18.00 |
$48,600 |
I/I |
(2,700) |
19,357 |
|
- |
|
703 Records found
|
|
Page 13 of 29 |
|
|
